|
Error creating thumbnail |
This article describes an exchange traded fund that tracks an index, commodity, currency, or varied basket of securites. View articles referencing this fund. |
Biotech HOLDRs ETF (BBH)
Biotech HOLDRs are depositary receipts issued by the Biotech HOLDRs Trust, and represent an undivided beneficial ownership in the common stock or American depositary shares of a group of specified companies that are involved in various segments of the biotechnology industry, when initially selected. Except when a reconstitution event, distribution of securities by an underlying issuer or other event occurs, the group of companies will not change. The Bank of New York is the trustee.
Company Name | % Net Assets |
Amgen, Inc. | 38.19% |
Gilead Sciences, Inc. | 29.00% |
Biogen Idec, Inc. | 13.27% |
Genzyme Corporation | 7.69% |
Life Technologies Corp | 4.10% |
Holdings as of 20/10/2009
ETF Name | Fund Manager | Expense Ratio |
Biotech HOLDRS ETF (BBH) | Merrill Lynch, Pierce, Fenner & Smith HOLDRS | N/A |
First Trust AMEX Biotechnology Index Fund (FBT) | First Trust Advisors L.P | 0.60% |
Global Biotech Portfolio ETF (PBTQ) | Invesco PowerShares | 0.75% |
iShares Nasdaq Biotechnology Index Fund (IBB) | ishares | 0.48% |
Powershares Dynamic Biotechnology & Genome Portfolio ETF (PBE) | Invesco PowerShares | 0.60% |
SPDR S&P Biotech ETF (XBI) | State Street Global Markets, LLC | 0.35% |